Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer

NCT00470704 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Lapatinib
DRUG: Herceptin

Sponsor

Nancy Lin, MD

Collaborators

[object Object]
[object Object]